Literature DB >> 22444504

Toxicology and characteristics of deaths involving zolpidem in New South Wales, Australia 2001-2010.

Shane Darke1, Mark Deady, Johan Duflou.   

Abstract

All cases presenting to the New South Wales Department of Forensic Medicine between January 1, 2001 and September 31, 2010 in which zolpidem was detected, were retrieved. A total of 91 cases were identified. The mean age was 49.4 years, 65.9% were male, and 61.5% were suicides. Zolpidem was a factor contributing to death in 35 (37.3%) cases, of which 31 (34.1%) involved zolpidem toxicity. The median blood zolpidem concentration was 0.20 mg/L (range 0.05-3.50 mg/L), with no significant gender difference. Drug toxicity cases involving zolpidem had significantly higher median blood zolpidem concentrations than other cases (0.50 vs. 0.10 mg/L). In 83.5% of cases, psychoactive substances other than zolpidem were detected, most commonly antidepressants (46.2%), benzodiazepines (35.2%), opioids (26.4%), and alcohol (39.6%). In summary, zolpidem was a factor contributing to death in a large proportion of cases, predominately involving drug toxicity and suicide.
© 2012 American Academy of Forensic Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22444504     DOI: 10.1111/j.1556-4029.2012.02117.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  4 in total

1.  Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study.

Authors:  Hi Gin Sung; Junquing Li; Jin Hyun Nam; Dae Yeon Won; BongKyoo Choi; Ju-Young Shin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-04-29       Impact factor: 4.328

Review 2.  Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

Authors:  W Vaughn McCall; Ruth M Benca; Peter B Rosenquist; Mary Anne Riley; Laryssa McCloud; Jill C Newman; Doug Case; Meredith Rumble; Andrew D Krystal
Journal:  Am J Psychiatry       Date:  2016-09-09       Impact factor: 18.112

Review 3.  The clinical and forensic toxicology of Z-drugs.

Authors:  Naren Gunja
Journal:  J Med Toxicol       Date:  2013-06

Review 4.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.